Millennium Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-141
| Closed | -$12.1K | – | 4165 |
|
|
2023
Q2 | $12.1K | Sell |
141
-119
| -46% | -$10.2K | ﹤0.01% | 4093 |
|
|
2023
Q1 | $109K | Buy |
260
+80
| +44% | +$33.5K | ﹤0.01% | 4041 |
|
|
2022
Q4 | $220K | Sell |
180
-33
| -15% | -$40.3K | ﹤0.01% | 4056 |
|
|
2022
Q3 | $169K | Sell |
213
-138
| -39% | -$109K | ﹤0.01% | 4518 |
|
|
2022
Q2 | $506K | Buy |
+351
| New | +$506K | ﹤0.01% | 3876 |
|
|
2021
Q4 | – | Sell |
-65
| Closed | -$411K | – | 5164 |
|
|
2021
Q3 | $411K | Sell |
65
-1
| -2% | -$6.32K | ﹤0.01% | 4304 |
|
|
2021
Q2 | $621K | Buy |
66
+61
| +1,220% | +$574K | ﹤0.01% | 4041 |
|
|
2021
Q1 | $43K | Buy |
+5
| New | +$43K | ﹤0.01% | 4382 |
|
|
2020
Q4 | – | Sell |
-6
| Closed | -$39 | – | 4068 |
|
|
2020
Q3 | $39 | Sell |
6
-49
| -89% | -$319 | ﹤0.01% | 3493 |
|
|
2020
Q2 | $413K | Buy |
55
+31
| +129% | +$233K | ﹤0.01% | 2831 |
|
|
2020
Q1 | $168K | Buy |
+24
| New | +$168K | ﹤0.01% | 2775 |
|
|
2019
Q4 | – | Sell |
-32
| Closed | -$305K | – | 3456 |
|
|
2019
Q3 | $305K | Buy |
+32
| New | +$305K | ﹤0.01% | 2948 |
|
|
2019
Q2 | – | Sell |
-51
| Closed | -$861K | – | 3476 |
|
|
2019
Q1 | $861K | Buy |
51
+46
| +920% | +$777K | ﹤0.01% | 2498 |
|
|
2018
Q4 | $44K | Sell |
5
-17
| -77% | -$150K | ﹤0.01% | 3235 |
|
|
2018
Q3 | $292K | Buy |
+22
| New | +$292K | ﹤0.01% | 3111 |
|
|
2016
Q3 | – | Sell |
-5
| Closed | -$29K | – | 3009 |
|
|
2016
Q2 | $29K | Sell |
5
-9
| -64% | -$52.2K | ﹤0.01% | 2858 |
|
|
2016
Q1 | $150K | Buy |
+14
| New | +$150K | ﹤0.01% | 2777 |
|